- Home
- ACRV vs LEGT Comparison
ACRV vs LEGT Comparison
Compare ACRV & LEGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACRV
- LEGT
- Stock Information
- Founded
- ACRV 2018
- LEGT 2023
- Country
- ACRV United States
- LEGT United States
- Employees
- ACRV N/A
- LEGT N/A
- Industry
- ACRV Medicinal Chemicals and Botanical Products
- LEGT
- Sector
- ACRV Health Care
- LEGT
- Exchange
- ACRV Nasdaq
- LEGT Nasdaq
- Market Cap
- ACRV 247.8M
- LEGT 265.3M
- IPO Year
- ACRV 2022
- LEGT 2024
- Fundamental
- Price
- ACRV $6.44
- LEGT $10.29
- Analyst Decision
- ACRV Strong Buy
- LEGT
- Analyst Count
- ACRV 5
- LEGT 0
- Target Price
- ACRV $22.40
- LEGT N/A
- AVG Volume (30 Days)
- ACRV 46.9K
- LEGT 37.0K
- Earning Date
- ACRV 11-13-2024
- LEGT 01-01-0001
- Dividend Yield
- ACRV N/A
- LEGT N/A
- EPS Growth
- ACRV N/A
- LEGT N/A
- EPS
- ACRV N/A
- LEGT N/A
- Revenue
- ACRV N/A
- LEGT N/A
- Revenue This Year
- ACRV N/A
- LEGT N/A
- Revenue Next Year
- ACRV N/A
- LEGT N/A
- P/E Ratio
- ACRV N/A
- LEGT N/A
- Revenue Growth
- ACRV N/A
- LEGT N/A
- 52 Week Low
- ACRV $3.19
- LEGT $10.00
- 52 Week High
- ACRV $11.90
- LEGT $10.47
- Technical
- Relative Strength Index (RSI)
- ACRV 31.95
- LEGT N/A
- Support Level
- ACRV $6.11
- LEGT N/A
- Resistance Level
- ACRV $8.35
- LEGT N/A
- Average True Range (ATR)
- ACRV 0.48
- LEGT 0.00
- MACD
- ACRV -0.23
- LEGT 0.00
- Stochastic Oscillator
- ACRV 12.55
- LEGT 0.00
About ACRV Acrivon Therapeutics Inc.
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.
About LEGT Legato Merger Corp. III
Legato Merger Corp III is a blank check company.